
Notable Analyst Updates – Spectranetics, HSBC, Verizon, New Home Company, Real Page
Sprectranetics (NASDAQ:SPNC) rose 10% and touched a 52-week high after the company said late Monday its trial using laser atherectomy to treat patients suffering from peripheral artery disease (PAD) had achieved statistical endpoints. Separately, Stifel Nicolas repeated its Buy recommendation on the stock and raised its price target to $30 from $24. Spectranetics, a maker of cardiovascular devices, said Monday it expects to submit a … Continue reading Notable Analyst Updates – Spectranetics, HSBC, Verizon, New Home Company, Real Page